Discover open access scientific publications

Search, annotate, share and cite publications

Publications by K. Lock

A Budget Impact Model for the Introduction of Bevacizumab for the Treatment of Newly Diagnosed Glioblastoma Multiforme in the UK

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Health Impact Assessment: Assessing Opportunities and Barriers to Intersectoral Health Improvement in an Expanded European Union

Journal of Epidemiology and Community Health
EpidemiologyPublic HealthOccupational HealthEnvironmental
2005English

Related publications

Cytotoxic Chemotherapeutic Management of Newly Diagnosed Glioblastoma Multiforme

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2009English

Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Using Temozolomide in Newly Diagnosed Glioblastoma Multiforme – A Single-Centre Experience

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2010English

Update and Developments in the Treatment of Glioblastoma Multiforme &Ndash; Focus on Bevacizumab

Pharmacogenomics and Personalized Medicine
Molecular MedicinePharmacology
2010English

Controversies in the Treatment of Elderly Patients With Newly Diagnosed Glioblastoma

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2013English

Single Dose Bevacizumab as Treatment for Symptomatic, Corticosteroid-Refractory Pseudoprogression After Chemoradiation Therapy for Newly Diagnosed Glioblastoma: A Case Report

Integrative Cancer Science and Therapeutics
2015English

Efficacy and Safety of Bevacizumab for the Treatment of Glioblastoma

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2015English

The Use of Anti-Gitr Antibody Treatment in a Murine Model of Glioblastoma Multiforme

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Plasma YKL-40 as a Biomarker for Bevacizumab Efficacy in Patients With Newly Diagnosed Glioblastoma in the Phase 3 Randomized AVAglio Trial

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy